Breaking News, Promotions & Moves

Shire

Philip J. Vickers, Ph.D., has been appointed senior vice president of R&D for Shire’s Human Genetic Therapies (HGT) business.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Philip J. Vickers, Ph.D., has been appointed senior vice president of R&D for Shire’s Human Genetic Therapies (HGT) business. Dr. Vickers will be responsible for leading global R&D for Shire HGT and for establishing the strategic direction of the company’s pipeline. He will report to Sylvie Gregoire, president of Shire HGT, and will play a central role in the development and execution of HGT’s global business strategy. Dr. Vickers joins the company from Resolvyx Pharmaceut...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters